Anand K Kondapi - Publications
Affiliations: | Biochemsitry | Life Sciences |
Year | Citation | Score | |||
---|---|---|---|---|---|
2021 | Yeruva SL, Kumar P, Deepa S, Kondapi AK. Lactoferrin nanoparticles coencapsulated with curcumin and tenofovir improve vaginal defense against HIV-1 infection. Nanomedicine (London, England). PMID 33660529 DOI: 10.2217/nnm-2020-0347 | 0.504 | |||
2020 | Senapathi J, Bommakanti A, Mallepalli S, Mukhopadhyay S, Kondapi AK. Sulfonate modified Lactoferrin nanoparticles as drug carriers with dual activity against HIV-1. Colloids and Surfaces. B, Biointerfaces. 191: 110979. PMID 32276212 DOI: 10.1016/j.colsurfb.2020.110979 | 0.366 | |||
2013 | Radhakrishna M, Durga K, Rao RK, Reddy DM, Kondapi AK. Factors associated with conversion of long-term non-progressors to progressors: a prospective study of HIV perinatally infected paediatric survivors. The Indian Journal of Medical Research. 138: 322-8. PMID 24135176 | 0.321 | |||
2013 | Bhaskar C, Reddy PS, Chandra KS, Sabde S, Mitra D, Kondapi AK. Identification of the potential regions of Epap-1 that interacts with V3 loop of HIV-1 gp120. Biochimica Et Biophysica Acta. 1834: 780-90. PMID 23360764 DOI: 10.1016/j.bbapap.2013.01.017 | 0.373 | |||
2011 | Gandapu U, Chaitanya RK, Kishore G, Reddy RC, Kondapi AK. Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro. Plos One. 6: e23388. PMID 21887247 DOI: 10.1371/journal.pone.0023388 | 0.463 | |||
2005 | Kondapi AK, Padmaja G, Satyanarayana N, Mukhopadyaya R, Reitz MS. A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus. Archives of Biochemistry and Biophysics. 441: 41-55. PMID 16091284 DOI: 10.1016/j.abb.2005.06.021 | 0.454 | |||
Show low-probability matches. |